Skip to main content scroll back to top of page

Chimerix is now part of Jazz Pharmaceuticals. Learn more at www.jazzpharma.com

Utility Navigation

Primary Navigation

Close Menu

Patients
- Expanded Access
- Clinical Trials
About Imipridones
- About Impipridones
  About ImpipridonesImipridones
  Oncology: Imipridones
  
  ONC201 dordaviprone for gliomas
  
  ONC206 for central nervous system tumors
  
  ONC212 IND-enabling studies
  
  Publications Neuro Oncology Publications 2024 SNO Annual Conference
Careers
Contact

BCV Publications

All Imipridones ONC201 ONC206 ONC212 Preclinical

Sorry, nothing to display.

Chimerix on LinkedIn
Chimerix on Twitter

Legal Menu

Privacy Notice
Cookie Notice
Terms & Conditions of Use
Forward-Looking Statements
Community Guidelines

© 2025 Copyright Chimerix. All rights reserved.

Chimerix is now part of Jazz Pharmaceuticals

Select Jazz for more information about Jazz Pharmaceuticals.
Select continue to proceed to the Chimerix website.

Jazz